Natural paclitaxel is a compound extracted from the cortex and bark of the yew tree and has a wide range of medicinal properties. It is an important anti-cancer substance and is considered one of the most effective drugs for many cancers.
The mechanism of action of natural paclitaxel is to inhibit the growth and proliferation of tumor cells by interfering with the mitomatous process of tumor cells. It is able to bind to tubulin and prevent the polymerization and depolymerization of tubulin during the mitos** process of tumor cells, thereby inhibiting the mitos** of tumor cells and inducing apoptosis of tumor cells. In addition, natural paclitaxel has anti-inflammatory and immunomodulatory effects.
Due to its anti-cancer properties, natural paclitaxel is widely used in clinical** cancers. At present, a variety of natural paclitaxel-based anti-cancer drugs have been developed, such as paclitaxel, docetaxel, paclitaxel esters, etc. These drugs are used for a variety of cancers such as breast, ovarian, lung, stomach, etc.
In addition to being an anti-cancer drug, natural paclitaxel also has other areas of application. For example, it can be used for cardiovascular disease and stroke, as it can reduce the proliferation of vascular endothelial cells and promote vasodilation. In addition, natural paclitaxel can also be used for autoimmune diseases such as rheumatoid arthritis due to its ability to regulate the function of the immune system.
In conclusion, natural paclitaxel is a very important compound with a wide range of medicinal properties. With the in-depth study of its mechanism of action and the expansion of its application field, it is believed that natural paclitaxel will play an increasingly important role in clinical practice.
Note: The potential efficacy and applications described in this article are derived from published literature.
Extended reading: Shanghai Zhuoding Biotechnology*** subsidiary has focused on the production of paclitaxel API for more than 20 years, and is an independent manufacturer of paclitaxel API approved by the US FDA, EDQM in Europe, TGA in Australia, CFDA in China, India, Japan and other national regulatory agencies. Shanghai Zhuoding paclitaxel raw materials, spot**, factory direct sales.